{"product_id":"birlafertility-business-model-canvas","title":"Birla Fertility \u0026 IVF Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock the Business Model Canvas for fertility clinics — value props, segments \u0026amp; revenue levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic blueprint behind Birla Fertility \u0026amp; IVF with our Business Model Canvas—detailing value propositions, customer segments, partners and revenue levers. Ideal for investors, consultants, and founders seeking actionable insights. Download the full Word \u0026amp; Excel canvas to benchmark and scale faster.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading IVF labs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartner with accredited embryology labs to ensure high-quality gamete handling and culture conditions, supporting industry benchmarks where live birth rates reach up to 50% for women under 35 and average about 30% per cycle in 2024. Joint protocols reduce variability and have been shown to improve success rates through standardized stimulation and transfer steps. Shared QA\/QC frameworks enable continuous outcome benchmarking across sites. Co-investment in lab tech shortens adoption cycles and drives efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOB-GYN \u0026amp; urology networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eReferral ties with OB-GYNs and andrologists leverage the WHO estimate that infertility affects about 1 in 6 couples, expanding patient inflow and strengthening pre\/post-procedure care. Shared care pathways streamline diagnostics and medication management, supporting IVF success rates that average ~30–35% per cycle for women under 35. CME programs and co-branded camps build clinician loyalty and referral density. Continuous data feedback loops track outcomes and enable iterative care improvements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma \u0026amp; consumables suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePharma and consumables suppliers secure fertility drugs, hormones, culture media and disposables at negotiated rates, supporting Birla Fertility’s cost control within India’s fertility market (~USD 1.3B in 2024). Vendor-managed inventory stabilizes supply for time-sensitive cycles and reduces stockouts; compliance systems enable batch traceability and 2–8°C cold-chain integrity; joint patient education raises adherence and protocol efficacy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostics \u0026amp; genetics labs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAlliances with diagnostics and genetics labs cover imaging, hormonal panels, AMH, semen analysis and PGT\/PGS; integrated reporting cut decision time ~30% in Birla Fertility 2024 pilot, enabling faster cycle adjustments. Standardized sample logistics keep sample error below 1% and turnaround to 24–48 hrs; co-development of panels raised actionable findings ~15% by tailoring to local populations.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCoverage: imaging, AMH, semen, PGT\/PGS\u003c\/li\u003e\n\u003cli\u003eDecision speed: -30% (2024 pilot)\u003c\/li\u003e\n\u003cli\u003eSample error: \u0026lt;1%\u003c\/li\u003e\n\u003cli\u003eTurnaround: 24–48 hrs\u003c\/li\u003e\n\u003cli\u003eActionable yield: +15% (locally tailored panels)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFintech \u0026amp; insurance partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eFintech and insurance partners provide EMIs, BNPL, and limited insurance cover—2024 adoption in Indian healthcare saw BNPL usage rise ~35% and EMIs accounted for ~30% of elective fertility bookings, lowering upfront costs and boosting conversions by ~18%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEMIs: reduced upfront payment\u003c\/li\u003e\n\u003cli\u003eBNPL: faster approvals\u003c\/li\u003e\n\u003cli\u003eInsurance: limited cost cover\u003c\/li\u003e\n\u003cli\u003ePre-approval: 40% faster booking\u003c\/li\u003e\n\u003cli\u003eOutcome-based packages: aligned incentives\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartnerships boost IVF success, speed diagnostics and expand payment access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships — accredited embryology labs, OB-GYN\/referral network, pharma\/consumables, diagnostics\/genetics, fintech\/insurers — drive higher success, faster decisions and cost access. 2024 metrics: IVF success ~30% per cycle, referral-driven inflow +25%, BNPL\/EMI use ~35%\/30%, diagnostics TAT 24–48 hrs. Shared QA, co-investment and outcome-data loops reduce variability and shorten adoption.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmbryology labs\u003c\/td\u003e\n\u003ctd\u003eQuality \u0026amp; tech\u003c\/td\u003e\n\u003ctd\u003eSuccess ~30%\/cycle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReferrals\u003c\/td\u003e\n\u003ctd\u003ePatient inflow\u003c\/td\u003e\n\u003ctd\u003e+25% inflow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFintech\u003c\/td\u003e\n\u003ctd\u003ePayment access\u003c\/td\u003e\n\u003ctd\u003eBNPL 35% \/ EMI 30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics\u003c\/td\u003e\n\u003ctd\u003eFaster decisions\u003c\/td\u003e\n\u003ctd\u003eTAT 24–48 hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas tailored to Birla Fertility \u0026amp; IVF, covering customer segments, channels, value propositions, key partners, activities, resources, cost structure and revenue streams across nine blocks; includes competitive advantages, linked SWOT analysis and polished narratives ideal for presentations, funding discussions and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Birla Fertility \u0026amp; IVF’s strategy into a digestible one-page canvas to quickly identify patient pain points, revenue streams, and care pathways. Perfect for teams and boardrooms to save hours structuring models, compare treatment-unit economics, and adapt operations or partnerships for faster decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eART procedures delivery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDeliver ART services—IVF, ICSI, IUI, egg\/sperm freezing, embryo transfer—under strict SOPs, with cycle planning, stimulation and monitoring individualized to patients; India per-cycle IVF cost ranges ~₹150,000–250,000 (2024) and clinical pregnancy rates average 30–40% for women \u0026lt;35 (2024). Lab workflows prioritize embryo viability using vitrification with \u0026gt;90% post-thaw survival (2024). Post-transfer luteal support and structured follow-up aim to maximize implantation and live-birth outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConduct fertility assessments including hormonal profiles and imaging, noting WHO estimates that 10–15% of couples experience infertility globally. Male factor contributes to roughly 50% of cases, so semen analysis and DNA fragmentation tests are standard to detect sperm defects. Genetic counseling and PGT are used where indicated to reduce aneuploidy-related losses, and continuous tracking of hormones and imaging refines treatment plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient counseling \u0026amp; care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProvide individualized counseling on clinical options, risks and out-of-pocket costs, with typical IVF cycle costs in India ranging about INR 150,000–300,000 (2024). Psychological support targets stress reduction and adherence to protocols, improving continuation of multi-cycle care. Transparent success metrics—national clinical pregnancy rates per transfer ~30–40% (2024)—guide realistic expectations. Structured follow-ups ensure continuity, protocol optimization and lifestyle interventions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality \u0026amp; compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eQuality \u0026amp; compliance at Birla Fertility ensures accreditation, strict infection control, and adherence to data privacy norms; outcomes are tracked via ICMR 2024 ART registry and internal KPIs. Routine audits and lab calibrations uphold consistency, while corrective actions and CAPA cycles drive ongoing clinical and operational improvement.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAccreditation \u0026amp; regulatory compliance\u003c\/li\u003e\n\u003cli\u003eInfection control protocols\u003c\/li\u003e\n\u003cli\u003eICMR 2024 registry + KPI monitoring\u003c\/li\u003e\n\u003cli\u003eAudits, calibrations, corrective actions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraining \u0026amp; research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eUpskill clinicians and embryologists via structured CME and high‑fidelity simulation to standardize procedures and reduce variability. Engage in multicenter clinical studies and protocol innovation, publishing outcomes to build institutional credibility and support referrals. Continuously evaluate emergent tech (time‑lapse imaging, AI morphokinetics), with 2024 adoption in advanced centers exceeding 50%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTraining: CME, simulation\u003c\/li\u003e\n\u003cli\u003eResearch: multicenter studies, protocol R\u0026amp;D\u003c\/li\u003e\n\u003cli\u003ePublications: outcome transparency\u003c\/li\u003e\n\u003cli\u003eTech evaluation: time‑lapse, AI morphokinetics (2024 \u0026gt;50% adoption in advanced centers)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive ART care: accredited IVF, PGT, SOPs, ₹150–300k per cycle; 30–40% pregnancy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDeliver ART (IVF\/ICSI\/IUI), diagnostics, PGT, counselling and follow-up under SOPs; per‑cycle cost ₹150k–300k (2024) with clinical pregnancy 30–40% for \u0026lt;35. Maintain accredited labs, ICMR 2024 reporting, audits, CAPA and staff training. Evaluate AI\/time‑lapse (adoption \u0026gt;50% in advanced centers 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIVF cost\u003c\/td\u003e\n\u003ctd\u003e₹150–300k\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePregnancy rate\u003c\/td\u003e\n\u003ctd\u003e30–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Birla Fertility \u0026amp; IVF Business Model Canvas, not a sample or mockup. Upon purchase you'll receive this exact file with all sections included, formatted and ready to edit. Delivery includes Word and Excel versions for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674978828665,"sku":"birlafertility-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/birlafertility-business-model-canvas.png?v=1755799610","url":"https:\/\/portersfiveforce.com\/products\/birlafertility-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}